Iterative Scopes, a 2017 spinout of MIT led by Jonathan Ng, announced today it closed a $30 million Series A financing led by new investors Obvious Ventures, with participation from Eli Lilly, Johnson & Johnson Innovation—JJDC Inc., venture capital firms Breyer Capital and Seae Ventures, and other leading healthcare investors. Proceeds from the investments will be used to continue developing the company’s AI-driven computational tools that help identify appropriate treatments and guide clinical trials for patients suffering from gastrointestinal diseases.
top of page
Search
Recent Posts
See AllBy: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...
Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...
Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...
bottom of page
Comments